share_log

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

POS AM:修改註冊聲明表
美股SEC公告 ·  2024/10/12 04:39

牛牛AI助理已提取核心訊息

Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc. has entered into an Equity Line Purchase Agreement with White Lion Capital LLC, which was established on October 9, 2023. Under this agreement, Aclarion has the discretion to sell up to $10 million worth of shares to White Lion, subject to specified terms and conditions. As part of the ongoing financial arrangement, Aclarion has already sold 1,800,000 shares of common stock to White Lion as of August 2024. Additionally, White Lion is covered by a Registration Statement filed on October 11, 2024, for the resale of up to 1,450,000 shares of Aclarion's common stock. The capital raised from these transactions is intended for general corporate purposes, including working capital. Aclarion, which trades under the ticker 'ACON' on the Nasdaq Capital Market, has faced compliance issues with Nasdaq's minimum bid price and stockholders' equity requirements, receiving deficiency letters. In response, Aclarion is planning a reverse stock split to meet the Bid Price Requirement and has appealed the delisting notices, actively seeking solutions to regain compliance with Nasdaq's standards.
Aclarion, Inc.已與White Lion Capital LLC簽訂了股權直通購買協議,該協議於2023年10月9日成立。根據該協議,Aclarion有權自行決定向White Lion出售最多1000萬美元的股票,但須遵守特定條款和條件。作爲持續的財務安排的一部分,截至2024年8月,Aclarion已經將180萬股普通股出售給了White Lion。此外,White Lion根據2024年10月11日提交的註冊聲明受益,可轉售Aclarion最多145萬股普通股。通過這些交易籌集的資金將用於一般企業用途,包括營運資金。在納斯達克資本市場以股票代碼'ACON'交易的Aclarion,面臨納斯達克最低買盤價格和股東權益要求的合規問題,收到了違規通知。作爲回應,Aclarion計劃進行股票的逆向拆分以滿足買盤價格要求,並已就除牌通知提出上訴,積極尋求解決方案以恢復符合納斯達克的標準。
Aclarion, Inc.已與White Lion Capital LLC簽訂了股權直通購買協議,該協議於2023年10月9日成立。根據該協議,Aclarion有權自行決定向White Lion出售最多1000萬美元的股票,但須遵守特定條款和條件。作爲持續的財務安排的一部分,截至2024年8月,Aclarion已經將180萬股普通股出售給了White Lion。此外,White Lion根據2024年10月11日提交的註冊聲明受益,可轉售Aclarion最多145萬股普通股。通過這些交易籌集的資金將用於一般企業用途,包括營運資金。在納斯達克資本市場以股票代碼'ACON'交易的Aclarion,面臨納斯達克最低買盤價格和股東權益要求的合規問題,收到了違規通知。作爲回應,Aclarion計劃進行股票的逆向拆分以滿足買盤價格要求,並已就除牌通知提出上訴,積極尋求解決方案以恢復符合納斯達克的標準。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。